PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
35266856-7	2022	Out of 1576, FDA-approved compounds, our study suggests three compounds: netupitant, paliperidone and vilazodone as possible inhibitors with a potential to inhibit both sites (monomeric and dimeric) of the Mpro.	Paliperidone Palmitate	85-97	NEWENTRY	Severe acute respiratory syndrome-related coronavirus	206-210